C-reactive protein and coronary heart disease: a critical review

Area of Science:

• Cardiovascular Medicine
• Inflammation Biology
• Biomarker Research

Background:

• C-reactive protein (CRP) is an acute phase protein with documented associations to coronary heart disease (CHD) risk.
• High CRP levels post-myocardial infarction correlate with mortality and adverse cardiac events.
• The precise clinical and pathogenic roles of CRP in these contexts remain debated.

Purpose of the Study:

• To critically evaluate the evidence linking C-reactive protein (CRP) to cardiovascular outcomes.
• To differentiate the significance of acute, high-level CRP responses versus modest, persistent elevations.
• To inform the ongoing debate regarding CRP's role in cardiovascular disease pathogenesis and risk.

Main Methods:

• Comprehensive review of large-scale epidemiological studies.
• Analysis of novel experimental research investigating CRP's mechanisms.
• Consideration of potential targeted therapies for modulating CRP.

Main Results:

• Distinguishes between CRP's role in acute injury settings versus chronic low-grade inflammation.
• Highlights the controversial nature of CRP's direct pathogenicity.
• Emphasizes the need for rigorous investigation into distinct CRP concentration patterns.

Conclusions:

• The clinical significance of CRP elevations varies depending on the context (acute vs. baseline).
• Further research is crucial to elucidate the direct pathogenic role of CRP in cardiovascular disease.
• Distinguishing between different CRP elevation patterns is key for accurate risk assessment and therapeutic strategies.